The new weight management ‘Tirzepatide’ medication (brand name Mounjaro®) will be available to NHS patients nationally from 23 June.
In Dorset around 1,000 people currently qualify for the medication based on national eligibility criteria – but it won’t be available locally until later this year (autumn) – so please don’t contact your GP just yet as they’re unable to help currently.
Who is eligible?
The first group of people eligible under the national criteria includes individuals who:
Have a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
and
Have at least four of the following long-term conditions:
Non-diabetic hyperglycaemia or type 2 diabetes
Hypertension (high blood pressure)
Dyslipidaemia
Established cardiovascular disease
Obstructive sleep apnoea
For more information visit: Tirzepatide (Mounjaro) – NHS Dorset
Source: NHS England Interim Commissioning Guidance
For more information visit: Tirzepatide (Mounjaro) – NHS Dorset